- QT Imaging Holdings, Inc. (QTIH, Financial) launches QTviewer 2.8 to boost clinical efficiency and diagnostic accuracy.
- The software supports direct PACS integration, real-time lesion analysis, and new RGB visualization modes.
- QTviewer 2.8 aims to transform QTI into a precision imaging AI company, enhancing patient experience and health outcomes.
QT Imaging Holdings, Inc. (OTCQB:QTIH), a leader in medical imaging technology, has unveiled QTviewer 2.8. This advanced software is designed to store and display images from the company's innovative QTscanâ„¢ technology, providing clinicians with a robust tool for non-invasive breast imaging. The QTviewer 2.8 aims to enhance the diagnostic workflow by providing a genuine 3D visualization of breast anatomy without the use of harmful radiation or compression, setting a new standard for safe and repeatable monitoring.
Some of the key features of QTviewer 2.8 include effortless, stateless DICOM viewing that allows instant access to QTscan studies without a preconfigured database. This feature is particularly useful for remote reads or low-resource environments. Furthermore, the software integrates real-time lesion doubling time analysis, which helps clinicians assess lesion growth within the standard reading workflow. This functionality enhances the monitoring of disease progression or treatment response without requiring contrast agents.
In addition, QTviewer 2.8 introduces new RGB visualization modes, which aid in interpreting anatomical structures and quantitative data. This enables clinicians to map the speed of sound, providing a visual representation of tissue composition. The advanced multi-series comparison allows radiologists to view multiple series from the same study simultaneously, improving anatomical and temporal comparisons. Furthermore, the new optimized viewport layouts for radiology workstations enhance ergonomics and diagnostic clarity.
Dr. Bilal Malik, QTI’s Chief Science Officer, expressed his excitement about the software's launch, noting that the company is on the path to becoming a precision imaging AI company. This goal is supported by proprietary AI/ML tools that accelerate image processing and reduce scanning time, ensuring a superior patient experience and improved health outcomes.
QT Imaging Holdings, Inc. is committed to transforming medical imaging by making it safer, more affordable, and centered on patient experience. For more information, visit the company's website at www.qtimaging.com.
